Caplight Directory>Companies>Euler Biologics-preview>Euler-bio


Euler Biologics

Euler Biologics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.euler.bio/

Last Round

Seed

Sep 1, 2024

Company Overview

Euler Biologics is a biotechnology company developing antibody-based therapies designed to preserve and enhance physical function for older adults.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibody therapieshealthy aginglongevitylongevity biotechbiologic drugsgerosciencedrug discoveryfunctional independencesarcopenia treatmentbiopharmaceutical productspre-clinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Euler Biologics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Euler Biologics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2024
View all Funding Rounds

Euler Biologics Investors

Notable investors and investment history

InvestorRounds
GaingelsSeed
Pillar VCSeed
Soma CapitalSeed
Axial VCSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2024

    Seed round raised from Gaingels, Pillar VC, Soma Capital, and Axial VC.

View all signals

Euler Biologics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Euler Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Euler Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2024
Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.